Erden Banoğlu

2.5k total citations
94 papers, 2.0k citations indexed

About

Erden Banoğlu is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Erden Banoğlu has authored 94 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Organic Chemistry, 34 papers in Pharmacology and 27 papers in Molecular Biology. Recurrent topics in Erden Banoğlu's work include Synthesis and biological activity (33 papers), Inflammatory mediators and NSAID effects (28 papers) and Asthma and respiratory diseases (11 papers). Erden Banoğlu is often cited by papers focused on Synthesis and biological activity (33 papers), Inflammatory mediators and NSAID effects (28 papers) and Asthma and respiratory diseases (11 papers). Erden Banoğlu collaborates with scholars based in Türkiye, Germany and Italy. Erden Banoğlu's co-authors include Burcu Çalışkan, Robert J. King, Oliver Werz, Mustafa Şahin, Serdar Ünlü, Gautam Jha, Abdurrahman Olğaç, Michael W. Duffel, Esra Küpeli̇ and İlkay Erdoğan Orhan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and The FASEB Journal.

In The Last Decade

Erden Banoğlu

88 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erden Banoğlu Türkiye 28 914 588 422 169 168 94 2.0k
Ana Luísa P. Miranda Brazil 27 1.5k 1.6× 618 1.1× 325 0.8× 124 0.7× 112 0.7× 89 2.6k
Daniela Ribeiro Portugal 28 602 0.7× 918 1.6× 389 0.9× 190 1.1× 97 0.6× 69 2.8k
Tadigoppula Narender India 28 1.1k 1.2× 892 1.5× 391 0.9× 233 1.4× 119 0.7× 125 2.7k
Pál Perjési Hungary 23 1.1k 1.2× 860 1.5× 374 0.9× 140 0.8× 51 0.3× 132 2.2k
Xiang‐Yang Ye China 25 711 0.8× 1.1k 1.9× 342 0.8× 129 0.8× 246 1.5× 79 2.4k
Fernanda M.F. Roleira Portugal 23 1.2k 1.3× 875 1.5× 487 1.2× 169 1.0× 74 0.4× 58 2.8k
Palwinder Singh India 23 1.2k 1.3× 499 0.8× 392 0.9× 96 0.6× 48 0.3× 104 1.9k
Zheying Zhu United Kingdom 25 787 0.9× 906 1.5× 443 1.0× 141 0.8× 180 1.1× 87 2.1k
Rosa Amoroso Italy 28 941 1.0× 1.1k 1.9× 166 0.4× 91 0.5× 359 2.1× 124 2.3k
Alessandra Ammazzalorso Italy 24 634 0.7× 837 1.4× 144 0.3× 65 0.4× 253 1.5× 90 1.6k

Countries citing papers authored by Erden Banoğlu

Since Specialization
Citations

This map shows the geographic impact of Erden Banoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erden Banoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erden Banoğlu more than expected).

Fields of papers citing papers by Erden Banoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erden Banoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erden Banoğlu. The network helps show where Erden Banoğlu may publish in the future.

Co-authorship network of co-authors of Erden Banoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Erden Banoğlu. A scholar is included among the top collaborators of Erden Banoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erden Banoğlu. Erden Banoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Olğaç, Abdurrahman, Paul M. Jordan, Christian Kretzer, Oliver Werz, & Erden Banoğlu. (2025). Discovery of novel microsomal prostaglandin E2 synthase 1 (mPGES-1) inhibitors by a structurally inspired virtual screening study. Journal of Molecular Graphics and Modelling. 136. 108962–108962.
3.
Saatci, Özge, Özge Akbulut, Metin Çetįn, et al.. (2023). Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification. Cell Death and Differentiation. 30(5). 1305–1319. 21 indexed citations
4.
Olğaç, Abdurrahman, et al.. (2023). Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5-Lipoxygenase-Activating Protein. ACS Omega. 8(34). 31293–31304. 2 indexed citations
5.
Kretzer, Christian, Paul M. Jordan, Rossella Bilancia, et al.. (2022). Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201. SHILAP Revista de lepidopterología. 18 indexed citations
6.
Aydın, Abdullah, et al.. (2021). Crystal structure and Hirshfeld surface analysis of 4-(4-chlorophenyl)-5-methyl-3-{4-[(2-methylphenyl)methoxy]phenyl}-1,2-oxazole. Acta Crystallographica Section E Crystallographic Communications. 77(4). 346–350. 2 indexed citations
7.
Akbulut, Özge, Özge Saatci, Urartu Özgür Şafak Şeker, et al.. (2020). A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate. Molecular Cancer Therapeutics. 19(6). 1243–1254. 21 indexed citations
8.
Kretzer, Christian, Paul M. Jordan, Paul Klemm, et al.. (2020). Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity. Journal of Nanobiotechnology. 18(1). 73–73. 26 indexed citations
9.
Boccellino, Mariarosaria, Maria Donniacuo, Ferdinando F. Bruno, et al.. (2019). Protective effect of piceatannol and bioactive stilbene derivatives against hypoxia-induced toxicity in H9c2 cardiomyocytes and structural elucidation as 5-LOX inhibitors. European Journal of Medicinal Chemistry. 180. 637–647. 35 indexed citations
10.
Nocentini, Alessio, et al.. (2019). Benzimidazole derivatives as potent and isoform selective tumor-associated carbonic anhydrase IX/XII inhibitors. Bioorganic Chemistry. 95. 103544–103544. 20 indexed citations
11.
Bruno, Ferdinando F., Simona Pace, Francesca Guida, et al.. (2018). Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO/m-PGES-1 dual inhibitors able to suppress inflammation. European Journal of Medicinal Chemistry. 155. 946–960. 18 indexed citations
12.
Olğaç, Abdurrahman, İlkay Erdoğan Orhan, & Erden Banoğlu. (2017). The Potential Role of In Silico Approaches to Identify Novel Bioactive Molecules from Natural Resources. Future Medicinal Chemistry. 9(14). 1665–1686. 37 indexed citations
13.
Orhan, İlkay Erdoğan, et al.. (2017). Pteryxin - A promising butyrylcholinesterase-inhibiting coumarin derivative from Mutellina purpurea. Food and Chemical Toxicology. 109(Pt 2). 970–974. 36 indexed citations
14.
Garscha, Ulrike, Simona Pace, Jana Gerstmeier, et al.. (2016). BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly. Biochemical Pharmacology. 119. 17–26. 40 indexed citations
15.
Banoğlu, Erden, Abdurrahman Olğaç, Jana Gerstmeier, et al.. (2016). 4,5-Diarylisoxazol-3-carboxylic acids: A new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein (FLAP). European Journal of Medicinal Chemistry. 113. 1–10. 48 indexed citations
16.
Baytaş, Sultan Nacak, Akın Yılmaz, Abdurrahman Olğaç, et al.. (2014). Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors. Bioorganic & Medicinal Chemistry. 22(12). 3096–3104. 52 indexed citations
17.
Banoğlu, Erden, et al.. (2012). Serum interleukin‐16 levels in patients with nasal polyposis. The Laryngoscope. 122(5). 961–964. 4 indexed citations
18.
Ünlü, Serdar, Erden Banoğlu, Antonio Entrena, et al.. (2008). Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors. European Journal of Medicinal Chemistry. 44(5). 1830–1837. 27 indexed citations
19.
20.
Gülcan, Hayrettin Ozan, Serdar Ünlü, Erden Banoğlu, et al.. (2003). Synthesis of New 4-(5-Chloro-2-oxo-3H-benzoxazol-3-yl)butanamide Derivatives and Their Analgesic and Anti-Inflammatory Properties. TURKISH JOURNAL OF CHEMISTRY. 27(4). 467–476. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Luísa P. Miranda Breakdown of academic impact, for papers by Daniela Ribeiro Breakdown of academic impact, for papers by Tadigoppula Narender Breakdown of academic impact, for papers by Pál Perjési Breakdown of academic impact, for papers by Xiang‐Yang Ye Breakdown of academic impact, for papers by Fernanda M.F. Roleira Breakdown of academic impact, for papers by Palwinder Singh Breakdown of academic impact, for papers by Zheying Zhu Breakdown of academic impact, for papers by Rosa Amoroso Breakdown of academic impact, for papers by Alessandra Ammazzalorso
Rankless by CCL
2026